🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dear Colleague, Join the Prostate Cancer Care Disparity Analysis Project (ProGAP) (NCT06612034) by taking our quick 6–8 minute survey on global disparities in prostate cancer treatment. Your input is vital in shaping better care. Thank you! Link👇👇👇 qualtricsxmvcbtqb5rf.qualtrics.com/jfe/form/SV_7a…

Pfizer España visibiliza la vida real de los pacientes con #cáncer f.mtr.cool/idrjpuydgz

Un joven de solo 19 años fue diagnosticado con Alzheimer… el primer caso registrado a una edad tan temprana que ha dejado perplejos a los científicos. Un giro inesperado en lo que creíamos saber sobre esta enfermedad. 👇 wp.me/p9eYmY-8bJ

#EmpowerGU fumar aumenta riesgo de cáncer de vejiga y riñon

FGFR inhibition in FGFR3 altered UC doesn’t get the attention it deserves #GUARDSymposium2025 Its data platinum refractory UC is similar to EV. It’s used in late disease. Sadly there are no R3s 1st line or combo studies. The survey below shows enthusiasm post EVP OncoAlert

With the final analysis of the last of the 1st line metastatic clear cell RCC trials combination trials it’s still fair to say ‘pick one and use it well’. #GUARDSymposium2025 Ipi/nivo is less good at getting initial control but has less long term toxicity. Brian Rini, MD OncoAlert

New treatments are changing the game for metastatic #ProstateCancer! Learn about the evolution of chemohormonal therapy & what's next in care from expert Pedro C Barata, MD MSc FACP Case Comp Cancer Ctr and Zach Klaassen Georgia Cancer Center > bit.ly/4dn5Vti #CancerResearch

Guillermo de Velasco Se ha sobrefocalizado tanto en el peligro "obvio" de cáncer de pulmón que estos datos sorprenden, como cuando descubren que supone también un incremento en el riesgo cardiaco.

🌟🚨 FGFR3-altered UC still overlooked! Despite solid data in platinum-refractory disease, FGFR inhibition lags behind in trials and attention. Important reminder by Tom Powles from #GUARDSymposium2025 👇 OncoAlert Enrique Grande Matt Galsky Andrea Necchi Daniel Castellano Javier Puente

Más información: uro-oncologia2025.com Auspicio institucional de la Asociación Argentina de Oncología Clínica

Dear Colleague, We invite you to join the Prostate Cancer Care Disparity Analysis Project (ProGAP) — [NCT06612034] — by completing our brief 6–8 minute survey exploring global disparities in prostate cancer treatment. Your voice is essential to shaping more equitable care

Huge Congratulations 🎉 to Dr. Aly-Khan Lalani (former Dana-Farber Lank Center for Genitourinary Oncology post-doc) who keeps pushing the boundaries and excelling, now Juravinski Research Institute in Canada 🇨🇦!

Thanks for advertising Advanced Prostate Cancer Consensus Conference and do not forget that registration is now open for 2026 on apccc.org for everyone interested. And we will for the first time also accept abstracts! Stay tuned for other news!

This month Editor Spotlight ESMO Open is on Karima Oualla, MD MSc (Karima Oualla, MD,MSc), Assistant Professor of Medical Oncology @ CHU Hassan II, Fes, Morocco. Specialty Editor ESMO Open, her research focuses on GU cancers, including rare ones. sciencedirect.com/journal/esmo-o…

💐 Día Internacional de las Técnicos en Cuidados Auxiliares de Enfermería. 🙌 El #Hospital12deOctubre destaca su labor con los pacientes y su integración en equipos multidisciplinares. 📸 Ana, #TCAE del '12', con una paciente en Medicina Fetal. #el12tecuida #somosdel12

Big news! #JCOPO is excited to announce Keyan Salari has joined us as an Associate Editor. Welcome aboard, Dr. Salari!

Just three days until KCRS 2025! We’re getting ready to welcome researchers, clinicians, advocates, and patients from around the world to explore the future of #KidneyCancer research. #KCRS25 #AcceleratingCures